The Complainant is F. Hoffmann-La Roche AG, of Basel, Switzerland.
The Respondent is NetMarketing cc, of Windhoek, Namibia.
2. The Domain Name and Registrar
The disputed domain name <valium-sale.com> is registered with CSL Computer
Service Langenbach GmbH dba Joker.com.
3. Procedural History
The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on November 24, 2005. On November 24, 2005, the Center transmitted by email to CSL Computer Service Langenbach GmbH dba Joker.com a request for registrar verification in connection with the domain name at issue. On November 28, 2005, CSL Computer Service Langenbach GmbH dba Joker.com transmitted by email to the Center its verification response confirming that the Respondent is listed as the registrant and providing the contact details for the administrative, billing, and technical contact. The Center verified that the Complaint satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”).
In accordance with the Rules, paragraphs 2(a) and 4(a), the Center formally notified the Respondent of the Complaint, and the proceedings commenced on December 14, 2005. In accordance with the Rules, paragraph 5(a), the due date for Response was January 3, 2006. The Respondent did not submit any response. Accordingly, the Center notified the Respondent’s default on January 5, 2006.
The Center appointed Mr. Ian Blackshaw as the Sole
Panelist in this matter on January 18, 2006. The Panel finds that it was properly
constituted. The Panel has submitted the Statement of Acceptance and Declaration
of Impartiality and Independence, as required by the Center to ensure compliance
with the Rules, paragraph 7.
4. Factual Background
The Complainant, together with its affiliated companies, is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics, with global operations in more than 100 countries.
The Complainant’s mark VALIUM is registered as a trademark in more than 100 countries worldwide. As an example, reference is made to the International Registration No. R250784, a copy of the registration certificate of which has been provided to the Panel. The priority date for this registration is December 20, 1961.
The mark VALIUM designates a sedative and anxiolytic drug belonging to the
benzodiazepine family, which has enabled the Complainant to build a world-wide
reputation in psychotropic medications.
5. Parties’ Contentions
A. Complainant
The Complainant makes the following contentions:
A. The domain name is confusingly similar to a trademark or service mark in which the Complainant has rights
The Domain Name of the Respondent is confusingly similar to the Complainant’s mark as it incorporates such mark in its entirety.
The mark VALIUM is well-known and notorious as evidenced by newspaper articles, copies of which have been provided to the Panel. The notoriety of this mark increases the likelihood of confusion.
Furthermore, the Complainant’s use and registration of the mark VALIUM predate the Respondent’s registration of the Domain Name at issue.
Therefore, the domain name is confusingly similar to the trademark of the Complainant.
B. The Respondent has no rights or legitimate interests in respect of the domain name
The Complainant has exclusive rights for the mark VALIUM, as mentioned above, and no license, permission, authorization or consent has been granted to the Respondent to use VALIUM in the domain name at issue.
Furthermore, it is obvious that the Respondent uses the domain name for commercial gain and with the purpose of capitalizing on the fame of the Complainant’s mark VALIUM.
Therefore, the domain name at issue clearly alludes to the Complainant.
Furthermore, according to the decision in Hoffmann-La Roche Inc. v. #1 Viagra
Propecia Xenical & More Online Pharmacy, WIPO
Case No. D2003-0793: “a reseller does not have the right to incorporate
the trademark of the resold goods into the domain name of the reseller.”
There is no reason why the Respondent should have any right or interest in the domain name.
C. The domain name was registered and is being used in bad faith
The domain name at issue was registered in bad faith, since, at the time of the registration, namely, January 5, 2003, the defendant had, no doubt, knowledge of the Complainant’s well-known product and mark VALIUM.
The domain name is also being used in bad faith. This is obvious, since, when viewing the Internet-website of the Respondent, a copy of which has been provided to the Panel, one realizes that the Respondent is intentionally attempting (for commercial purpose) to attract Internet users to the Respondent’s website, by creating a likelihood of confusion with the Complainant’s well-known mark as to the source, affiliation and endorsement of Respondent’s website.
The domain name misleadingly includes the Complainant’s mark in spite of no authorization having been granted to the Respondent. The use of the domain name is potentially harmful to the health of Internet users, who purchase VALIUM products under the mistaken impression that they are dealing with the Complainant.
B. Respondent
The Respondent, having been duly notified of the Complaint
and these proceedings, did not reply to the Complainant’s contentions
or take any other part in these proceedings.
6. Discussion and Findings
To qualify for cancellation or transfer of the domain name at issue, the Complainant must prove each of the following elements of paragraph 4(a) of the Policy, namely:
(i) The disputed domain name is identical or confusingly similar to a trademark or service mark in which Complainant has rights; and
(ii) Respondent has no rights or legitimate interests in respect of the domain name; and
(iii) The disputed domain name has been registered and is being used in bad faith.
In accordance with paragraph 15(a) of the Rules, the Panel shall decide the Complaint on the basis of the statements and documents submitted and in accordance with the Policy, the Rules, and any rules and principles of law that it deems applicable.
In accordance with paragraph 14(a) of the Rules, in the event that a Party, in the absence of exceptional circumstances, does not comply with any of the time periods established by the Rules or the Panel, the Panel shall proceed to a decision on the Complaint; and (b) if a Party, in the absence of exceptional circumstances, does not comply with any provision of, or requirement under the Rules, or any request from the Panel, the Panel shall draw such inferences as it considers appropriate.
In accordance with paragraph 10(d) of the Rules, the Panel shall determine the admissibility, relevance, materiality and weight of the evidence.
In previous UDRP cases in which the respondent failed
to file a response, the panels’ decisions were based upon the complainant’s
assertions and evidence, as well as inferences drawn from the respondent’s
failure to reply. See The Vanguard Group, Inc. v. Lorna Kang, WIPO
Case No. D2002-1064; and also Köstritzer Schwarzbierbrauerei v. Macros-Telekom
Corp, WIPO Case No. D2001-0936.
Nevertheless, the Panel must not decide in the Complainant’s
favor solely based on the Respondent’s default (Cortefiel S.A. v. Miguel
García Quintas, WIPO Case No. D2000-0140).
The Panel must decide whether the Complainant has introduced elements of proof,
which allow the Panel to conclude that its allegations are true.
A. Identical or Confusingly Similar
It is established case law that where a domain name
incorporates a complainant’s registered mark, this is sufficient to establish
that the domain name is identical or confusingly similar for the purposes of
the Policy. See Magnum Piering, Inc. v. The Mudjackers and Garwood S. Wilson,
Sr., WIPO Case No. D2000-1525.
The domain name at issue incorporates the trademark VALIUM, which is owned and has been commercially used and promoted by the Complainant in and for the purposes of its business and the sale of its products as a trademark for many years. Furthermore, the Panel accepts and recognizes the Complainant’s contention that its trademark VALIUM is notorious and well-known globally.
Furthermore, the Panel would add that the addition of the word “sale” (even with the hyphen to make a compound word) is descriptive and provides no distinctiveness or source of origin elements whatsoever to the domain name at issue, which essentially incorporates the Complainant’s trademark VALIUM.
In view of this, the Panel finds that the domain name registered by the Respondent is identical or confusingly similar to the trademark VALIUM, in which the Complainant has clearly demonstrated, to the satisfaction of the Panel, that it has well-established and commercially valuable rights through registration and long exclusive commercial use.
B. Rights or Legitimate Interests
In order to determine whether the Respondent has any rights or legitimate interests in respect of the domain name (paragraphs 3(b)(ix)(2) of the Rules and 4(c) of the Policy), attention must be paid to any of the following circumstances in particular but without limitation:
- Whether before any notice to the Respondent of the dispute, there is any evidence of the Respondent’s use of, or demonstrable preparations to use, the domain name or a name corresponding to the domain name in connection with a bona fide offering of goods or services;
- Whether the Respondent (as an individual, business, or other organization) has been commonly known by the domain name, even if the Respondent has acquired no trademark or service mark rights;
- Whether the Respondent is making a legitimate non-commercial or fair use of the domain name, without intent for commercial gain misleadingly to divert consumers or to tarnish the trademark or service mark at issue.
There is no evidence to show that the Respondent was acting in pursuance of any rights or legitimate interests when registering the domain name at issue.
In particular, the Panel finds no evidence that the Respondent has used, or undertaken any demonstrable preparations to use, the domain name at issue in connection with a bona fide offering of goods or services. On the contrary, the Respondent has used the domain name at issue for a website that suggests it is that of the Complainant.
Likewise, no evidence has been adduced that the Respondent has commonly been known by the domain name; nor is it making a legitimate non-commercial or fair use of the domain name; nor has the Respondent been authorized or licensed by the Complainant to use the Complainant’s well-known trademark VALIUM as part of the domain name at issue.
Furthermore, the adoption by the Respondent of a domain name identical to the Complainant’s trademark inevitably leads to the diversion of the Complainant’s consumers to the Respondent’s website (see further on this point below) and the consequential tarnishing of the Complainant’s valuable trademark. In other words, the Respondent is trading for commercial gain on the good name and worldwide fame and reputation of the Complainant’s business and trademark and unfairly attracting to its own business and activities the substantial goodwill that the Complainant has established over many years in its name and registered marks, evidence of which has been provided to the Panel, without any right or legal justification for doing so.
Therefore, the Panel concludes that the Respondent has neither rights to nor legitimate interests in the domain name at issue.
C. Registered and Used in Bad Faith
Regarding the bad faith requirement, paragraph 4(b)
of the Policy lists four examples of acts, which prima facie constitute
evidence of bad faith. However, this list is not exhaustive, but merely illustrative.
See Nova Banka v. Iris, WIPO Case No. D2003-0366.
Paragraph 4(b)(iv) of the Policy is particularly relevant to the present case and provides that there is evidence of bad faith in the following circumstances:
“(iv) by using the domain name, the respondent has intentionally attempted to attract, for commercial gain, Internet users to its website or other on-line location, by creating a likelihood of confusion with the complainant’s mark as to the source, sponsorship, affiliation, or endorsement of the respondent’s website or location or of a product or service on its website or location.”
Based on the evidence provided in the case file, the Panel agrees with the Complainant’s contention that the Respondent, by registering the domain name at issue, is trading on the Complainant’s valuable goodwill established in its trademark VALIUM over many years. Indeed, in the absence of any evidence to the contrary, of which none is forthcoming on the part of the Respondent, the Respondent’s registration of the domain name at issue would not appear to be accidental, but deliberate and calculated to exploit the Complainant’s renown in the pharmaceuticals’ field.
Again, by registering and using the domain name at issue incorporating the Complainant’s trademark, VALIUM, the Respondent is misleading Internet users and consumers into thinking that it is, in some way or another, connected, sponsored or affiliated with the Complainant and its business, or the Respondent’s activities are approved or endorsed by the Complainant, none of which, in fact, is the case.
The Respondent appears to be trading on the Complainant’s
goodwill and reputation, which the Complainant has built up over many years.
This, without any explanations by the Respondent to the contrary, of which none
have been forthcoming, constitutes bad faith. See the case of eBay Inc. v.
Sunho Hong, WIPO Case No. D2000-1633,
where it was stated that:
“The Domain Name consists of the EBAY trademark plus the addition of the country name Korea. Because the Domain Name incorporates the identical EBAY trademark, a consumer or user of the Internet viewing a website located at the “www.ebaykorea.com” domain address would be likely to assume that the website or operator is somehow sponsored by or affiliated with eBay, when it is not.”
Furthermore, the failure of the Respondent to file any answer to the present Complaint or otherwise participate in the present proceedings, in the view of the Panel, also suggests bad faith on the part of the Respondent.
Finally, the Panel agrees with the Complainant’s contention that the use of the domain name at issue by the Respondent, which is potentially harmful to the health of Internet users and consumers who purchase VALIUM products under the mistaken impression that they are dealing with the Complainant, is further evidence of bad faith on the part of the Respondent.
Therefore, for all the above reasons, the Panel concludes that the Respondent
has registered and is using the domain name at issue in bad faith.
7. Decision
For all the foregoing reasons, in accordance with paragraphs 4(i) of the Policy and 15 of the Rules, the Panel orders that the domain name <valium-sale.com> be transferred to the Complainant.
Ian Blackshaw
Sole Panelist
Dated: January 19, 2006
Stay updated! Get new cases and decisions by daily email.
